Live birth achieved despite the absence of ejaculated spermatozoa and mature oocytes retrieved: a case report.
Zuzana HolubcováPavel OtevřelMarek KoudelkaSoňa KloudováPublished in: Journal of assisted reproduction and genetics (2021)
The most common reason for in vitro fertilization (IVF) cycle cancelation is a lack of quality gametes available for intracytoplasmic sperm injection (ICSI). Here we present the successful fertility treatment of the couple affected by obstructive azoospermia combined with suboptimal response to controlled ovarian stimulation. Since the conventional approach appeared ineffective to overcome both partners' specific problems, the targeted interventions, namely, (1) pharmacological enhancement of sperm motility and (2) polarized light microscopy (PLM)-guided optimization of ICSI time, were applied to rescue the cycle with only immature oocytes and immotile testicular sperm retrieved. The treatment with theophylline aided the selection of viable spermatozoa derived from cryopreserved testicular tissue. When the traditional stimulation protocol failed to produce mature eggs, non-invasive spindle imaging was employed to adjust the sperm injection time to the maturational stage of oocytes extruding a polar body in vitro. The fertilization of 12 late-maturing oocytes yielded 5 zygotes, which all developed into blastocysts. One embryo was transferred into the uterus on day 5 post-fertilization, and another 3 good quality blastocysts were vitrified for later use. The pregnancy resulted in a full-term delivery of a healthy child. This case demonstrates that the individualization beyond the standard IVF protocols should be considered to maximize the chance of poor-prognosis patients to achieve pregnancy with their own gametes.
Keyphrases
- pregnancy outcomes
- poor prognosis
- mental health
- pregnant women
- long non coding rna
- end stage renal disease
- high resolution
- chronic kidney disease
- newly diagnosed
- quality improvement
- ejection fraction
- staphylococcus aureus
- peritoneal dialysis
- escherichia coli
- germ cell
- ultrasound guided
- cystic fibrosis
- pseudomonas aeruginosa
- replacement therapy
- patient reported outcomes
- bone marrow
- hiv infected